In Vivo Molecular Prediction of Carbonic Anhydrase IX-G250MN Expression on Immunotherapy Outcome in Renal Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-1512
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A 99mTc-Labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma in Vivo

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis

Frontiers in Oncology
Cancer ResearchOncology
2016English

Reply: Expression of Carbonic Anhydrase IX Suggests Poor Response to Therapy in Rectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2009English

Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness

Metabolites
BiochemistryEndocrinologyMetabolismMolecular BiologyDiabetes
2018English

In Vivo Imaging and Quantification of Carbonic Anhydrase IX Expression as an Endogenous Biomarker of Tumor Hypoxia

PLoS ONE
Multidisciplinary
2012English

Agents Described in the Molecular Imaging and Contrast Agent Database for Imaging Carbonic Anhydrase IX Expression

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2014English

Carbonic Anhydrase IX—Mouse Versus Human

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Prostate Cancer Cells and Exosomes in Acidic Condition Show Increased Carbonic Anhydrase IX Expression and Activity

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2019English

Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy